152 related articles for article (PubMed ID: 8673714)
1. Gastrointestinal contrast agents for MR imaging.
Brown JJ
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714
[TBL] [Abstract][Full Text] [Related]
2. [The use of high concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent: application in MR cholangiography].
Takahara T; Saeki M; Nosaka S; Shimoyamada K; Suemitsu I; Nakajima Y; Yoshikawa T; Ishikawa T
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Aug; 55(9):697-9. PubMed ID: 7478957
[TBL] [Abstract][Full Text] [Related]
3. MR contrast agents, the old and the new.
Bellin MF
Eur J Radiol; 2006 Dec; 60(3):314-23. PubMed ID: 17005349
[TBL] [Abstract][Full Text] [Related]
4. [New development of cellulose-ferric ammonium citrate solution as a contrast-enhancement agent for magnetic resonance imaging of esophageal diseases].
Ogawa Y; Noda Y; Sawada A; Fujiwara Y; Hamada N; Terashima M; Inomata T; Yoshida S; Morio K
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Oct; 54(12):1178-80. PubMed ID: 9261198
[TBL] [Abstract][Full Text] [Related]
5. Targeted contrast agents in MR imaging.
Gupta H; Weissleder R
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):171-84. PubMed ID: 8673713
[TBL] [Abstract][Full Text] [Related]
6. [High concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent].
Takahara T; Yoshikawa T; Saeki M; Nosaka S; Shimoyamada K; Nakajima Y; Ishikawa T
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):425-6. PubMed ID: 7617470
[TBL] [Abstract][Full Text] [Related]
7. [MR imaging of colonic cancer with retrograde administration of contrast material containing ferric ammonium citrate].
Mizuguchi M; Matsuo Y; Fukahori T; Kudo S
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1063-5. PubMed ID: 8587850
[TBL] [Abstract][Full Text] [Related]
8. [Clinical efficacy of suppression and visualization of the duodenal fluid in MR cholangiopancreatography using ferric ammonium citrate].
Takahara T; Kurihara Y; Takahashi M; Nakajima Y; Ishikawa T
Nihon Rinsho; 1998 Nov; 56(11):2865-9. PubMed ID: 9847611
[TBL] [Abstract][Full Text] [Related]
9. Contrast agents for functional and cellular MRI of the kidney.
Grenier N; Pedersen M; Hauger O
Eur J Radiol; 2006 Dec; 60(3):341-52. PubMed ID: 16973326
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of cartilage: evaluation and comparison of MR imaging techniques.
Balkissoon A
Top Magn Reson Imaging; 1996 Feb; 8(1):57-67. PubMed ID: 8820095
[TBL] [Abstract][Full Text] [Related]
11. [MR imaging oral contrast agent mixed with milk for the small intestine].
Hirohashi S; Hirohashi R; Uchida H; Kitano S; Tanaka M; Matsuo N; Ohishi H
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):784-8. PubMed ID: 8072869
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging.
Ito K
Eur J Radiol; 2006 May; 58(2):186-99. PubMed ID: 16413154
[TBL] [Abstract][Full Text] [Related]
13. Contrast agents for MR imaging of the liver.
Balci NC; Semelka RC
Radiol Clin North Am; 2005 Sep; 43(5):887-98, viii. PubMed ID: 16098345
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of the liver. Contrast agents.
Mahfouz AE; Hamm B
Magn Reson Imaging Clin N Am; 1997 May; 5(2):223-40. PubMed ID: 9113673
[TBL] [Abstract][Full Text] [Related]
15. MR imaging of CNS tumors: are all contrast agents created the same?
Essig M
Neuroradiology; 2006 Apr; 48 Suppl 1():3-8. PubMed ID: 16699847
[TBL] [Abstract][Full Text] [Related]
16. [Elimination of artifacts in MRCP: technical consideration].
Ohgi K; Satoh K; Tanaka S; Higami T; Furukawa T; Akiyama H; Kimura S; Uehara K; Murata K; Higashi M
Nihon Rinsho; 1998 Nov; 56(11):2854-8. PubMed ID: 9847609
[TBL] [Abstract][Full Text] [Related]
17. An overview of MR arthrography with emphasis on the current technique and applicational hints and tips.
Sahin G; Demirtaş M
Eur J Radiol; 2006 Jun; 58(3):416-30. PubMed ID: 16464555
[TBL] [Abstract][Full Text] [Related]
18. Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver.
Low RN
Top Magn Reson Imaging; 1998 Jun; 9(3):141-66. PubMed ID: 9621404
[TBL] [Abstract][Full Text] [Related]
19. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced MR imaging of gynecologic disorders.
Outwater EK
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):133-51. PubMed ID: 8673711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
